Meijuan Sui
No. 23 Youzheng Street
Harbin, 150001, China
Harbin, 150001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 07, 2023
Combined immune and DDR pathway classifier: A novel pathway-based classification aimed at tailoring personalized therapies for acute myeloid leukemia patients.
Journal: Computers in biology and medicine
Published: April 15, 2023
A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers.
Journal: Frontiers in immunology
Published: April 09, 2023
IL1RA mediated the effects of aspirin on COVID-19 severity: A Mendelian randomization study.
Journal: The Journal of infection
Published: January 14, 2023
Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment.
Journal: Biological trace element research
Published: September 07, 2022
Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 06, 2021
Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
Journal: Chinese medical journal
Published: October 02, 2014
Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide.
Journal: Leukemia & lymphoma
Published: January 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026